Collegium Pharmaceutical COLL
NASDAQ COLL
$22.02 +0.18 (+0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2026)

Updated

Collegium Pharmaceutical's Amortizatization of Intangibles was $62.95 million in Q2 2026, up 13.5% from $55.47 million a year earlier and up 13.5% from the prior quarter.

Analysis

Collegium Pharmaceutical (COLL) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Collegium Pharmaceutical's Amortizatization of Intangibles was $229.37 million through Jun 30, 2026, up 10.7% year-over-year; for FY2025, it was $221.89 million, up 34.2% from FY2024.

  • Amortizatization of Intangibles has now increased for six consecutive years, with a five-year compound annual growth rate of 29.6% (FY2020 to FY2025).
  • In earlier years, Amortizatization of Intangibles was $165.3 million in FY2024 (+13.4%), $145.76 million in FY2023 (+7.0%), $136.26 million in FY2022 (+102.8%) and $67.18 million in FY2021 (+10.7%).
  • The Q2 2026 figure marks the highest quarterly Amortizatization of Intangibles in data going back to Q2 2017.
  • Compared with a year earlier, Amortizatization of Intangibles was higher in six of the last eight quarters, with growth averaging 30.5%.
  • The best year-over-year quarter for Amortizatization of Intangibles over five years was Q4 2022 (growth of 151.7%); the worst was Q4 2023 (a decline of 18.4%).
  • Per Business Quant data, COLL's Amortizatization of Intangibles in the three quarters before Q2 2026 was $55.47 million (Q1 2026), $55.47 million (Q4 2025) and $55.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. of Intangibles (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 984.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 600.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Collegium Pharmaceutical 715.61 Mn -508.15 Mn 110.29 Mn 62.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62.95 Mn
Mar 31, 2026 55.47 Mn
Dec 31, 2025 55.47 Mn
Sep 30, 2025 55.47 Mn
Jun 30, 2025 55.47 Mn
Mar 31, 2025 55.47 Mn
Dec 31, 2024 55.47 Mn
Sep 30, 2024 40.80 Mn
Jun 30, 2024 34.52 Mn
Mar 31, 2024 34.52 Mn
Dec 31, 2023 34.51 Mn
Sep 30, 2023 36.32 Mn
Jun 30, 2023 37.46 Mn
Mar 31, 2023 37.47 Mn
Dec 31, 2022 42.28 Mn
Sep 30, 2022 37.55 Mn
Jun 30, 2022 37.50 Mn
Mar 31, 2022 18.92 Mn
Dec 31, 2021 16.80 Mn
Sep 30, 2021 16.80 Mn
API Access

Collegium Pharmaceutical Amortizatization of Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=COLL&period=max&api_key=YOUR_API_KEY